Control of biochemical reactions through supramolecular RING domain self-assembly

被引:96
作者
Kentsis, A [1 ]
Gordon, RE [1 ]
Borden, KLB [1 ]
机构
[1] NYU, Mt Sinai Sch Med, Dept Physiol & Biophys, Struct Biol Program, New York, NY 10029 USA
关键词
protein association; supramolecular scaffold; catalytic surface;
D O I
10.1073/pnas.202608799
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
RING domains act in a variety of unrelated biochemical reactions, with many of these domains forming key parts of supramolecular assemblies in cells. Here, we observe that purified RINGs from a variety of functionally unrelated proteins, including promyelocytic leukemia protein, KAP-1/TIF1beta, Z, Mel18, breast cancer susceptibility gene product 1 (BRCA1), and BRCA1-associated RING domain (BARD1), self-assemble into supramolecular structures in vitro that resemble those they form in cells. RING bodies form polyvalent binding surfaces and scaffold multiple partner proteins. Separation of RING bodies from monomers reveals that self-assembly controls and amplifies their specific activities in two unrelated biochemistries: reduction of 5' mRNA cap affinity of elF4E by promyelocytic leukemia protein and Z, and E3 ubiquitin conjugation activity of BARD1:BRCA1. Functional significance of self-assembly is underscored by partial restoration of assembly and E3 activity of cancer predisposing BRCA1 mutant by forced oligomerization. RING self-assembly creates bodies that act structurally as polyvalent scaffolds, thermodynamically by amplifying activities of partner proteins, and catalytically by spatiotemporal coupling of enzymatic reactions. These studies reveal a general paradigm of how supramolecular structures may function in cells.
引用
收藏
页码:15404 / 15409
页数:6
相关论文
共 27 条
[1]   The BRCA1/BARD1 heterodimer, a tumor suppressor complex with ubiquitin E3 ligase activity [J].
Baer, R ;
Ludwig, T .
CURRENT OPINION IN GENETICS & DEVELOPMENT, 2002, 12 (01) :86-91
[2]   THE SOLUTION STRUCTURE OF THE RING FINGER DOMAIN FROM THE ACUTE PROMYELOCYTIC LEUKEMIA PROTO-ONCOPROTEIN PML [J].
BORDEN, KLB ;
BODDY, MN ;
LALLY, J ;
OREILLY, NJ ;
MARTIN, S ;
HOWE, K ;
SOLOMON, E ;
FREEMONT, PS .
EMBO JOURNAL, 1995, 14 (07) :1532-1541
[3]   Two RING finger proteins, the oncoprotein PML and the arenavirus Z protein, colocalize with the nuclear fraction of the ribosomal P proteins [J].
Borden, KLB ;
Campbelldwyer, EJ ;
Carlile, GW ;
Djavani, M ;
Salvato, MS .
JOURNAL OF VIROLOGY, 1998, 72 (05) :3819-3826
[4]   BRCA1 RING domain cancer-predisposing mutations - Structural consequences and effects on protein-protein interactions [J].
Brzovic, PS ;
Meza, JE ;
King, MC ;
Klevit, RE .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (44) :41399-41406
[5]   Structure of a BRCA1-BARD1 heterodimeric RING-RING complex [J].
Brzovic, PS ;
Rajagopal, P ;
Hoyt, DW ;
King, MC ;
Klevit, RE .
NATURE STRUCTURAL BIOLOGY, 2001, 8 (10) :833-837
[6]   Autoubiquitination of the BRCA1-BARD1 RING ubiquitin ligase [J].
Chen, A ;
Kleiman, FE ;
Manley, JL ;
Ouchi, T ;
Pan, ZQ .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (24) :22085-22092
[7]   ABERRANT SUBCELLULAR-LOCALIZATION OF BRCA1 IN BREAST-CANCER [J].
CHEN, YM ;
CHEN, CF ;
RILEY, DJ ;
ALLRED, DC ;
CHEN, PL ;
VONHOFF, D ;
OSBORNE, CK ;
LEE, WH .
SCIENCE, 1995, 270 (5237) :789-791
[8]   PML RING suppresses oncogenic transformation by reducing the affinity of eIF4E for mRNA [J].
Cohen, N ;
Sharma, M ;
Kentsis, A ;
Perez, JM ;
Strudwick, S ;
Borden, KLB .
EMBO JOURNAL, 2001, 20 (16) :4547-4559
[9]   The lymphocytic choriomeningitis virus RING protein Z associates with eukaryotic initiation factor 4E and selectively represses translation in a RING-dependent manner [J].
Dwyer, EJC ;
Lai, HK ;
MacDonald, RC ;
Salvato, MS ;
Borden, KLB .
JOURNAL OF VIROLOGY, 2000, 74 (07) :3293-3300
[10]   The RING heterodimer BRCA1-BARD1 is a ubiquitin ligase inactivated by a breast cancer-derived mutation [J].
Hashizume, R ;
Fukuda, M ;
Maeda, I ;
Nishikawa, H ;
Oyake, D ;
Yabuki, Y ;
Ogata, F ;
Ohta, T .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (18) :14537-14540